基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
---|---|---|---|---|---|
P2RY8 | 0 | 0 | |||
P4HB | 0 | 0 | |||
PABPC1 | 0 | 0 | |||
PABPC3 | 0 | 0 | |||
PAG1 | 0 | 0 | |||
PAK1 | 0 | 0 | |||
PAK3 | 0 | 0 | |||
PAK5 | 0 | 0 | |||
PAK6 | 0 | 0 | |||
Pak7 | 0 | 0 | |||
PALB2 | 乳腺癌,胰腺癌,前列腺癌 | 丝裂霉素C,奥拉帕利, | 2 | 3 | |
PALLD | 0 | 0 | |||
PAPOLG | 0 | 0 | |||
PAPPA2 | 肺腺癌 | 派姆单抗(帕博利珠单抗), | 1 | 1 | |
PAQR8 | 0 | 0 | |||
PARK2 | 0 | 0 | |||
PARP1 | 周围神经鞘恶性肿瘤 | 奥拉帕利, | 1 | 1 | |
PARP2 | 0 | 0 | |||
PARP3 | 0 | 0 | |||
PARP4 | 0 | 0 | |||
PASK | 0 | 0 | |||
PAX3 | 0 | 0 | |||
PAX5 | 小儿B淋巴细胞白血病 | 1 | 2 | ||
PAX7 | 0 | 0 | |||
PAX8 | 女性生殖器官癌 | 2 | 2 | ||
PBK | 胃腺癌,非小细胞肺癌 | 吉非替尼, | 2 | 2 | |
PBLD | 肝细胞癌 | 1 | 1 | ||
PBRM1 | 透明细胞肾细胞癌,肾细胞癌 | 阿特朱单抗,阿替利珠单抗,阿维单抗 巴文西亚,度伐利尤单抗,德瓦鲁单抗,CTLA-4 Inhibitor,依维莫司,伊匹单抗,PD-L1 Antibody,派姆单抗(帕博利珠单抗),纳武单抗(纳武利尤单抗), | 2 | 5 | |
PBX1 | 0 | 0 | |||
PC | 0 | 0 | |||
PCBP1 | 0 | 0 | |||
PCDH10 | 0 | 0 | |||
PCDH17 | 0 | 0 | |||
PCDH18 | 0 | 0 | |||
PCDH9 | 0 | 0 | |||
PCK1 | 0 | 0 | |||
PCLO | 0 | 0 | |||
PCSK6 | 0 | 0 | |||
PCSK7 | 0 | 0 | |||
PDCD1 | 0 | 0 | |||
PDCD11 | 0 | 0 | |||
PDCD1LG2 | 头颈癌 | 派姆单抗(帕博利珠单抗), | 1 | 1 | |
PDCD4 | 肺癌 | 紫杉醇, | 1 | 1 | |
PDE11A | 0 | 0 | |||
PDE1C | 0 | 0 | |||
PDE3A | 0 | 0 | |||
PDE4D | 0 | 0 | |||
PDE4DIP | 0 | 0 | |||
PDE6C | 0 | 0 | |||
PDGFB | 小儿B淋巴细胞白血病 | 达沙替尼,伊马替尼, | 1 | 1 | |
PDGFRA | 癌症,慢性骨髓单核细胞白血病,胃肠道间质瘤,非小细胞肺癌,黑色素瘤,骨髓和淋巴肿瘤伴嗜酸性粒细胞增多和pdgfra,pdgfrb和fgfr1异常 | Crenolanib,达沙替尼,伊马替尼,Imatinib Mesylate,帕纳替尼/普纳替尼/波纳替尼,舒尼替尼, | 21 | 45 | |
PDGFRB | 急性淋巴细胞白血病,成人B淋巴细胞白血病,慢性骨髓单核细胞白血病,慢性骨髓增生性疾病,血液学癌症,小儿B细胞急性淋巴细胞白血病,小儿B细胞淋巴细胞白血病 | 巴非替尼,CHZ868,达沙替尼,伊马替尼,尼洛替尼,帕纳替尼/普纳替尼/波纳替尼,Rebastinib, | 4 | 11 | |
PDHA2 | 0 | 0 | |||
PDILT | 0 | 0 | |||
PDK1 | 0 | 0 | |||
PDPK1 | 0 | 0 | |||
PDPN | 0 | 0 | |||
PDYN | 0 | 0 | |||
PDZRN3 | 0 | 0 | |||
PEG3 | 0 | 0 | |||
PER1 | 0 | 0 | |||
PGBD1 | 0 | 0 | |||
PGR | 乳腺癌 | 依西美坦, | 他莫昔芬, | 1 | 4 |
PH0X2B | 0 | 0 | |||
PHF1 | 0 | 0 | |||
PHF20L1 | 0 | 0 | |||
PHF6 | 0 | 0 | |||
PHF7 | 0 | 0 | |||
PHLPP2 | 0 | 0 | |||
PHOX2B | 0 | 0 | |||
PIBF1 | 0 | 0 | |||
PIGF | 0 | 0 | |||
PIK3C2A | 0 | 0 | |||
PIK3C2B | 0 | 0 | |||
PIK3C2G | 0 | 0 | |||
PIK3C3 | 0 | 0 | |||
PIK3CA | 乳腺癌,癌症,宫颈癌,结直肠癌,子宫内膜癌,上皮性卵巢癌,雌激素受体阳性乳腺癌,胃腺癌,多形性胶质母细胞瘤,头颈癌,头颈鳞状细胞癌,HER2受体阳性乳腺癌,侵袭性管状乳腺癌,lunG腺癌,非小细胞肺癌,黑色素瘤,默克尔细胞癌,胃癌,甲状腺癌 | Tanespimycin,Ado-trastuzumab,阿法替尼,阿培利司,Anti-EGFR Monoclonal Antibody,Apitolisib,阿司匹林,Capivasertib,贝伐单抗,Dactolisib,Buparlisib,卡博替尼,Celecoxib,西妥昔单抗,CH5132799,厄洛替尼,依维莫司,氟维司群,吉非替尼,布洛芬,艾代拉里斯,拉帕替尼,MK-2206,Dactolisib,哌柏西利,帕博西尼,帕博西林,帕尼单抗,Perifosine,PI103,PI3K Inhibitor,Pictilisib,Torkinib,Radiation,西罗莫司,瑞戈非尼,瑞博西尼,Ridaforolimus,Taselisib,曲美替尼,曲妥珠单抗,维莫非尼, | 氟尿嘧啶,顺铂,环磷酰胺,多柔比星,表柔比星,伊立替康,奥沙利铂,紫杉醇,舒林酸,他莫昔芬, | 40 | 265 |
PIK3CB | 0 | 0 | |||
PIK3CD | 0 | 0 | |||
PIK3CG | 0 | 0 | |||
PIK3R1 | 乳腺癌,多形性胶质母细胞瘤 | Buparlisib,Torkinib, | 1 | 2 | |
PIK3R2 | 黑色素瘤 | 维莫非尼, | 2 | 2 | |
PIK3R3 | 0 | 0 | |||
PIM1 | 非小细胞肺癌 | 1 | 1 | ||
PIP5K1A | 0 | 0 | |||
PKD1L2 | 0 | 0 | |||
PKD2 | 0 | 0 | |||
PKHD1 | 0 | 0 | |||
PLA2G1B | 0 | 0 | |||
PLAC8 | 0 | 0 | |||
PLAG1 | 0 | 0 | |||
PLCB1 | 0 | 0 | |||
PLCG1 | 0 | 0 | |||
PLCG2 | 慢性淋巴细胞白血病 | 1 | 1 | ||
PLEKHA1 | 0 | 0 | |||
PLEKHH2 | 0 | 0 | |||
PLK1 | 0 | 0 | |||
PLK2 | 0 | 0 | |||
PLPPR4 | 0 | 0 | |||
PLXNA1 | 0 | 0 | |||
PLXNB2 | 0 | 0 | |||
PMAIP1 | 0 | 0 | |||
PML | 急性早幼粒细胞白血病 | All-trans Retinoic Acid, | 三氧化二砷, | 4 | 7 |
PMS1 | 0 | 0 | |||
PMS2 | 多形性胶质母细胞瘤,林奇综合征 | 纳武单抗(纳武利尤单抗), | 2 | 2 | |
PNO1 | 0 | 0 | |||
PNPLA3 | 0 | 0 | |||
PNRC1 | 0 | 0 | |||
POLD1 | 肺腺癌,非小细胞肺癌 | 派姆单抗(帕博利珠单抗), | 3 | 3 | |
POLD3 | 0 | 0 | |||
POLDIP2 | 0 | 0 | |||
POLE | 结直肠癌,子宫内膜癌,多形性胶质母细胞瘤 | 派姆单抗(帕博利珠单抗), | 4 | 5 | |
POLE4 | 肺腺癌 | 派姆单抗(帕博利珠单抗), | 1 | 1 | |
POLG | 0 | 0 | |||
POLH | 0 | 0 | |||
POLM | 0 | 0 | |||
POLN | 0 | 0 | |||
POLQ | 0 | 0 | |||
POLR2B | 0 | 0 | |||
POM121 | 0 | 0 | |||
POM121L12 | 0 | 0 | |||
POT1 | 慢性淋巴细胞白血病 | 1 | 1 | ||
POTEG | 0 | 0 | |||
POU2AF1 | 0 | 0 | |||
POU5F1 | 结肠癌 | 奥沙利铂, | 1 | 1 | |
PPARD | 0 | 0 | |||
PPARG | 0 | 0 | |||
PPHLN1 | 0 | 0 | |||
PPM1D | 0 | 0 | |||
PPP1R15A | 结直肠癌 | 贝伐单抗,FOLFIRI Regimen, | 1 | 1 | |
PPP1R17 | 0 | 0 | |||
PPP2R1A | 0 | 0 | |||
PPP2R2A | 0 | 0 | |||
PPP2R5B | 0 | 0 | |||
PPP4R2 | 0 | 0 | |||
PPP6C | 0 | 0 | |||
PRAM1 | 0 | 0 | |||
PRCC | 0 | 0 | |||
PRDM1 | 弥漫性大B细胞淋巴瘤 | 1 | 2 | ||
PRDM14 | 0 | 0 | |||
PRDM16 | 0 | 0 | |||
PREX2 | 黑色素瘤 | 维莫非尼, | 1 | 1 | |
PRF1 | 0 | 0 | |||
PRIM2 | 0 | 0 | |||
PRKAA1 | 0 | 0 | |||
PRKAA2 | 癌症 | ACLY SiRNA, | 1 | 1 | |
PRKACA | 肝细胞纤维板层癌,肝细胞混合纤维板层癌 | 1 | 4 | ||
PRKACB | 0 | 0 | |||
PRKACG | 0 | 0 | |||
PRKAR1A | 0 | 0 | |||
PRKCA | 0 | 0 | |||
PRKCB | 成人T细胞白血病 | 1 | 1 | ||
PRKCE | 0 | 0 | |||
PRKCG | 0 | 0 | |||
PRKCI | 0 | 0 | |||
PRKD1 | 0 | 0 | |||
PRKDC | 0 | 0 | |||
PRKN | 0 | 0 | |||
PROKR2 | 0 | 0 | |||
PROM1 | 肝细胞癌 | 索拉非尼, | 1 | 1 | |
PRPF39 | 0 | 0 | |||
PRPF40B | 0 | 0 | |||
PRRT2 | 0 | 0 | |||
PRRX1 | 0 | 0 | |||
PRSS1 | 0 | 0 | |||
PRSS3 | 0 | 0 | |||
PRSS8 | 0 | 0 | |||
PRX | 0 | 0 | |||
PSG2 | 0 | 0 | |||
PSIP1 | 0 | 0 | |||
PSMB1 | 0 | 0 | |||
PSMB2 | 0 | 0 | |||
PSMB5 | 0 | 0 | |||
PSMB8 | 胃腺癌 | 1 | 1 | ||
PSMD4 | 乳腺癌,结直肠癌 | 卡非佐米,他拉唑帕尼, | 2 | 2 | |
PTCH1 | 基底细胞癌,脑髓母细胞瘤,癌,髓母细胞瘤 | 索尼德吉,维莫德吉, | 7 | 8 | |
PTCH2 | 0 | 0 | |||
PTEN | 膀胱癌,乳腺癌,癌症,结直肠癌,子宫内膜癌,子宫内膜增生,胃腺癌,多形胶质母细胞瘤,头颈癌,头颈鳞状细胞癌,Her2受体阳性乳腺癌,黑色素瘤,卵巢癌,胰腺癌,前列腺癌腺癌,前列腺癌,pten错构瘤肿瘤综合征,皮肤黑色素瘤,实体瘤,胃癌,甲状腺癌 | Tanespimycin,Capivasertib,AZD8186,Buparlisib,阿培利司,西妥昔单抗,Chemotherapy,达可替尼,EGFR Inhibitor,恩扎鲁胺,厄洛替尼,依维莫司,氟维司群,吉非替尼,Uprosertib,Ipatasertib,拉帕替尼,LY294002,MK-2206,MTOR Inhibitors,帕尼单抗,PD184352,Perifosine,Pictilisib,Torkinib,Ridaforolimus,Taselisib,西罗莫司,曲妥珠单抗,维莫非尼, | 卡铂,顺铂,多西他赛,紫杉醇, | 8 | 53 |
PTGIS | 0 | 0 | |||
PTGS1 | 0 | 0 | |||
PTGS2 | 结直肠癌 | 阿司匹林, | 1 | 1 | |
PTK2 | 0 | 0 | |||
PTK2B | 小儿B细胞急性淋巴细胞白血病 | 2 | 2 | ||
PTK6 | 0 | 0 | |||
PTP4A1 | 0 | 0 | |||
PTP4A3 | 结直肠癌 | 西妥昔单抗, | 1 | 1 | |
PTPN11 | 少年骨髓单核细胞白血病,喉癌,毛细胞星形细胞瘤 | 3 | 3 | ||
PTPN12 | 三受体阴性乳腺癌 | 克唑替尼,舒尼替尼, | 1 | 1 | |
PTPN13 | 0 | 0 | |||
PTPN2 | 0 | 0 | |||
PTPN22 | 0 | 0 | |||
PTPN6 | 肝细胞癌 | 1 | 1 | ||
PTPRB | 血管肉瘤 | 舒尼替尼, | 1 | 1 | |
PTPRD | 骨尤文氏肉瘤,头颈癌 | 西妥木单抗,JSI-124,R1507, | 2 | 2 | |
PTPRF | 非小细胞肺癌 | Erlotinib Hydrochloride, | 1 | 2 | |
PTPRJ | 0 | 0 | |||
PTPRK | 0 | 0 | |||
PTPRO | 0 | 0 | |||
PTPRS | 0 | 0 | |||
PTPRT | 头颈部鳞状细胞癌 | JSI-124,Stattic, | 1 | 1 | |
PTPRU | 0 | 0 | |||
PTPRZ1 | 0 | 0 | |||
PTTG1 | 脑膜瘤 | 1 | 1 | ||
PURA | 0 | 0 | |||
PXDNL | 肺腺癌 | 派姆单抗(帕博利珠单抗), | 1 | 1 |